Combination regimens. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Cell Line, Tumor Antilymphocyte Serum

Organisms5

HIV-1 Mice, Nude Helicobacter pylori Transplantation Chimera HIV

Diseases40

Leukopenia Lung Neoplasms Neoplasm Metastasis Neutropenia Carcinoma, Non-Small-Cell Lung Malaria, Falciparum Neoplasms Lymphoma, Non-Hodgkin Thrombocytopenia Breast Neoplasms HIV Infections Adenocarcinoma Multiple Myeloma Colorectal Neoplasms Testicular Neoplasms Disease Progression Neoplasm Recurrence, Local Recurrence Ovarian Neoplasms Stomach Neoplasms Nausea Vomiting Graft vs Host Disease Hodgkin Disease Hematologic Diseases Acute Disease Hematologic Neoplasms Helicobacter Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Disease Models, Animal Fever Tuberculosis, Pulmonary Leukemia Carcinoma, Small Cell Tuberculosis Tuberculosis, Multidrug-Resistant Leukemia, Myeloid, Acute Stomatitis Body Weight Lymphoma

Chemicals and Drugs127

Diosmin Deoxycytidine Antineoplastic Agents Fluorouracil Cisplatin Paclitaxel Drug Combinations Vinblastine Mefloquine Cyclophosphamide Doxorubicin Organoplatinum Compounds Carboplatin Boronic Acids Pyrazines Antineoplastic Agents, Phytogenic Camptothecin Taxoids Artemisinins Antimetabolites, Antineoplastic Vidarabine Anti-HIV Agents Topotecan Thalidomide Antimalarials Anti-Bacterial Agents Leucovorin Vincristine Mitoxantrone Ifosfamide Epirubicin Rifampin Antibodies, Monoclonal, Humanized Methotrexate Sesquiterpenes Antibodies, Monoclonal Antibiotics, Antineoplastic Angiogenesis Inhibitors Interferon-alpha Etoposide Prednisone Immunosuppressive Agents Cytarabine Busulfan Benzoxazines Antitubercular Agents HIV Protease Inhibitors Bleomycin Ritonavir Reverse Transcriptase Inhibitors Nevirapine Amoxicillin Antineoplastic Agents, Alkylating Melphalan Pyrazinamide Isoniazid Clarithromycin Procarbazine Dacarbazine Stavudine Metronidazole Organophosphonates Lopinavir Bismuth Dexamethasone Antibiotics, Antitubercular Oxazines Ethambutol Anti-Retroviral Agents Granulocyte Colony-Stimulating Factor Prednisolone Anti-Ulcer Agents Antibodies, Monoclonal, Murine-Derived Lamivudine Anthracyclines Carmustine Anti-Infective Agents Mycophenolic Acid Zidovudine Dideoxynucleosides Ofloxacin Tacrolimus Omeprazole Pyrimidinones Cyclosporine Myeloablative Agonists Aza Compounds Quinolines Azithromycin Antiemetics Adenine Doxycycline Mechlorethamine Antilymphocyte Serum Thiotepa Didanosine Fluorenes Ondansetron Nelfinavir Idarubicin Gentamicins Levofloxacin Vindesine Penicillins 2-Pyridinylmethylsulfinylbenzimidazoles Tegafur Ranitidine Mesna Lomustine Amikacin Antiviral Agents Recombinant Proteins Asparaginase Rifabutin Insulin, Long-Acting Diarylquinolines Methylprednisolone Mitomycin Penicillin G Procaine Saquinavir Furazolidone Hypoglycemic Agents RNA, Viral Vancomycin Tinidazole Lansoprazole Primaquine

Analytical, Diagnostic and Therapeutic Techniques and Equipment63

Antineoplastic Combined Chemotherapy Protocols Drug Therapy, Combination Drug Administration Schedule Treatment Outcome Infusions, Intravenous Administration, Oral Clinical Trials, Phase II as Topic Survival Analysis Clinical Trials as Topic Treatment Failure Clinical Trials, Phase III as Topic Survival Rate Area Under Curve Combined Modality Therapy Disease-Free Survival Drug Evaluation Salvage Therapy Microbial Sensitivity Tests Neoplasm Staging Randomized Controlled Trials as Topic Remission Induction Chemotherapy, Adjuvant Prospective Studies Follow-Up Studies Prognosis Transplantation Conditioning Retrospective Studies Antiretroviral Therapy, Highly Active Hematopoietic Stem Cell Transplantation Double-Blind Method Viral Load Transplantation, Autologous Whole-Body Irradiation Transplantation, Homologous Bone Marrow Transplantation CD4 Lymphocyte Count Injections, Intravenous Pilot Projects Random Allocation Immunization, Secondary Injections, Intramuscular Kaplan-Meier Estimate Cohort Studies Neoadjuvant Therapy Cross-Over Studies Risk Factors Maximum Tolerated Dose Injections, Subcutaneous Kidney Transplantation Feasibility Studies Drug Monitoring Drug Dosage Calculations Disease Models, Animal Immunosuppression Drug Substitution Multivariate Analysis Hematopoietic Stem Cell Mobilization Colony Count, Microbial Actuarial Analysis Peripheral Blood Stem Cell Transplantation Antibiotic Prophylaxis Body Weight Stem Cell Transplantation

Psychiatry and Psychology2

Patient Compliance Medication Adherence

Phenomena and Processes17

Drug Synergism Dose-Response Relationship, Drug Area Under Curve Drug Interactions Time Factors Drug Resistance, Neoplasm Apoptosis Viral Load CD4 Lymphocyte Count Drug Resistance, Viral Graft Survival Half-Life Graft Rejection Maximum Tolerated Dose Pregnancy Drug Resistance, Multiple, Viral Body Weight

Information Science1

Health Care29

Treatment Outcome Clinical Trials, Phase II as Topic Survival Analysis Clinical Trials as Topic Treatment Failure Clinical Trials, Phase III as Topic Survival Rate Area Under Curve Disease-Free Survival Randomized Controlled Trials as Topic Prospective Studies Follow-Up Studies Retrospective Studies Patient Compliance Double-Blind Method Pilot Projects Random Allocation Medication Adherence Kaplan-Meier Estimate Cohort Studies Cross-Over Studies Risk Factors Feasibility Studies Drug Substitution Multivariate Analysis Actuarial Analysis Age Factors Cost-Benefit Analysis Infectious Disease Transmission, Vertical

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Drug Therapy, Combination Drug Administration Schedule Treatment Outcome Diosmin Deoxycytidine Antineoplastic Agents Fluorouracil Cisplatin Paclitaxel Drug Combinations Vinblastine Mefloquine Drug Synergism Infusions, Intravenous Cyclophosphamide Administration, Oral Doxorubicin Organoplatinum Compounds Carboplatin Clinical Trials, Phase II as Topic Boronic Acids Survival Analysis Pyrazines Antineoplastic Agents, Phytogenic Camptothecin Taxoids Dose-Response Relationship, Drug Clinical Trials as Topic Leukopenia Artemisinins Antimetabolites, Antineoplastic Vidarabine Lung Neoplasms Anti-HIV Agents Treatment Failure Topotecan Clinical Trials, Phase III as Topic Thalidomide Antimalarials Anti-Bacterial Agents Survival Rate Leucovorin Neoplasm Metastasis Area Under Curve Vincristine Drug Interactions Mitoxantrone Ifosfamide Epirubicin Rifampin Antibodies, Monoclonal, Humanized Methotrexate Sesquiterpenes Neutropenia Combined Modality Therapy Disease-Free Survival Drug Evaluation Salvage Therapy Time Factors Carcinoma, Non-Small-Cell Lung Microbial Sensitivity Tests Neoplasm Staging Malaria, Falciparum Antibodies, Monoclonal Neoplasms Lymphoma, Non-Hodgkin Thrombocytopenia Breast Neoplasms HIV Infections Drug Resistance, Neoplasm Randomized Controlled Trials as Topic Remission Induction Adenocarcinoma Multiple Myeloma Chemotherapy, Adjuvant Antibiotics, Antineoplastic Colorectal Neoplasms Angiogenesis Inhibitors Testicular Neoplasms Prospective Studies Disease Progression Neoplasm Recurrence, Local Follow-Up Studies Recurrence Ovarian Neoplasms Stomach Neoplasms Interferon-alpha Prognosis Cell Line, Tumor HIV-1 Mice, Nude Apoptosis Etoposide Prednisone Transplantation Conditioning Retrospective Studies Immunosuppressive Agents Cytarabine Antiretroviral Therapy, Highly Active

No FAQ available that match "combination regimens"